The Rs 3,866 crore pharma major Lupin Ltd is likely to go in for overseas acquisitions within 6 to 9 months. Lupin is negotiating with a few companies in
The Mumbai-based company has been on a buying spree. It acquired a company, Kyowa, in
Calculators
Invest Confidently
Explore
Compare everything
See all plans, pricing and what each product includes side by side.
Plans & Subscriptions| Sr. No. | Received from | Pending at the end of last month | Received | Resolved* | Total Pending # | Pending complaints >3months | Average Resolution time^ (in days) |
|---|---|---|---|---|---|---|---|
| 1 | Directly from Investors | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | SEBI (SCORES) | 0 | 0 | 0 | 0 | 0 | 0 |
| 3 | Other Sources (if any) | 0 | 0 | 0 | 0 | 0 | 0 |
| Grand Total | 0 | 0 | 0 | 0 | 0 | 0 |
^ Average Resolution time is the sum total of time taken to resolve each complaint in days, in the current month divided by total number of complaints resolved in the current month.
| Sr. No. | Month | Carried forward from previous month | Received | Resolved* | Pending# |
|---|---|---|---|---|---|
| 1 | Jun, 2026 | 0 | 0 | 0 | 0 |
| 2 | Jul, 2026 | 0 | 0 | 0 | 0 |
| 3 | Aug, 2026 | 0 | 0 | 0 | 0 |
| Grand Total | 0 | 0 | 0 | 0 |
| Sr. No. | Fin. Year | Carried forward from previous year | Received | Resolved* | Pending# |
|---|---|---|---|---|---|
| 1 | 2022-23 | 0 | 1 | 1 | 0 |
| 2 | 2023-24 | 0 | 0 | 0 | 0 |
| 3 | 2024-25 | 0 | 0 | 0 | 0 |
| 4 | 2025-26 | 0 | 1 | 1 | 0 |
| Grand Total | 0 | 2 | 2 | 0 |
The Rs 3,866 crore pharma major Lupin Ltd is likely to go in for overseas acquisitions within 6 to 9 months. Lupin is negotiating with a few companies in
The Mumbai-based company has been on a buying spree. It acquired a company, Kyowa, in
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1885.90 |
| Dr. Reddys Labs. | 1382.00 |
| Cipla | 1413.50 |
| Lupin | 1977.00 |
| Zydus Lifesciences | 1189.00 |
| View more.. | |